Open original FDA record ↗Recall record
- FDA identifier
- Z-1926-2016
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Jun 7, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Loss of therapy during recharging of device. Reportedly, a charging session was terminated prior to obtaining recharge threshold voltage of 3.615, which triggered rapid battery depletion state. As a result, the device depleted to 1.925 volts in one to two days rather than the typical 30 days. Insufficient coupling between recharger and device during recharge session was found to be key factor.
Source facts
- Action
- Consignees were sent on 5/3/2016 a Medtronic "Urgent Medical Device Safety notification" letter dated May 2016. The letter was addressed to "Healthcare Professional". The letter described the problem and the product involved in the recall. The letter listed the recommendation to patients to follow current recharge instructions, paying particular attention to Charging Efficiency and Battery Charge Level indicators on the recharger. Consignees were also requested to complete and return the "Physician Reply Form:. For questions contact Medtronic Neuromodulation Technical services at 1-800-707-0933 weekdays 7 am - 6 pm CST.
- Initiated
- 2016-05-03
- Root cause
- Under Investigation by firm
- Terminated
- 2017-08-04
- Distribution
- Worldwide Distribution
- Recall number
- Z-1926-2016
- Recall status
- Terminated
- CDRH record ID
- 146106
- FDA classified
- 2016-06-07
- Recall event number
- 74059